Androgen deprivation therapy for prostate cancer is associated in increased risk for biliary disease

BACKGROUND: Androgen deprivation therapy (ADT) for prostate cancer produces benefits in several clinical situations but has adverse metabolic effects including obesity, increased abdominal girth, increased triglycerides, and insulin resistance. Each of these is a risk factor for gallstone disease. A...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eur Urol
Hlavní autoři: Saylor, Philip J., Smith, Matthew R., O'Malley, A. James, Keating, Nancy L.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4535925/
https://ncbi.nlm.nih.gov/pubmed/23428068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2013.02.003
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky